Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes
More topics under "A61K - Preparations for medical, dental, or toilet purposes" (2,585,043)
A61K 101 - Radioactive non-metals (526)
A61K 103 - Radioactive metals (481)
A61K 125 - Containing or obtained from roots, bulbs, tubers, corms or rhizomes (2,645)
A61K 127 - Containing or obtained from leaves (1,806)
A61K 129 - Containing or obtained from bark (325)
A61K 131 - Containing or obtained from seeds, nuts, fruits or grains (1,932)
A61K 133 - Containing or obtained from flowers or blossoms (665)
A61K 135 - Containing or obtained from stems, stalks, branches, twigs or shoots (756)
A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213)
A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
A61K 36 - Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines (179,316)
A61K 38 - Medicinal preparations containing peptides (316,240)
A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation (9,445)
A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
A61K 49 - Preparations for testing in vivo (35,376)
A61K 50 - Electrically conductive preparations for use in therapy or testing in vivo, e.g. conductive adhesives or gels to be used with electrodes for electrocardiography (ecg) or for transcutaneous drug administration (62)
A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
A61K 6 - Preparations for dentistry (18,259)
A61K 8 - Cosmetics or similar toilet preparations (170,551)
A61K 9 - Medicinal preparations characterised by special physical form (299,044)
Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449)
10/2005
10/12/2005EP1583971A2 Modulation of deubiquitinase family members
10/12/2005EP1583826A2 Inhibition of e3-ubiquitin ligase hakai for treatment of proliferative disorders
10/12/2005EP1583557A2 Vaccine compositions and methods
10/12/2005EP1583552A2 Antineoplastic ether lipid compounds
10/12/2005EP1583549A2 Peptide yy analogs
10/12/2005EP1583539A2 Paricalcitol as a chemotherapeutic agent
10/12/2005EP1583517A2 Methods and products for treating staphylococcal infections
10/12/2005EP1583507A2 Magnesium salt of imidazole derivative
10/12/2005EP1583506A2 Eye-drop vaccine containing copolymer 1 for therapeutic immunization
10/12/2005EP1583504A2 Methods and compositions for the diagnosis, prognosis, and treatment of cancer
10/12/2005EP1583503A2 Multivalent lymphotoxin beta receptor agonists and therapeutic uses thereof
10/12/2005EP1583499A2 A novel polyherbal preparation for the prevention of atherosclerosis and hyperlipidemia
10/12/2005EP1583473A2 Nanoparticle based stabilization of ir fluorescent dyes
10/12/2005CN1681800A Process for preparing prostaglandin derivatives and starting materials for the same
10/12/2005CN1681784A Azabicyclo derivatives as muscarinic receptor antagonists
10/12/2005CN1681536A Method of preparing dry powder inhalation compositions
10/12/2005CN1681523A Composition and method for lowering cholesterol
10/12/2005CN1681386A Compositions and products containing s-equol, and methods for their making
10/12/2005CN1680378A Pyrazolo(4, 3-d)pyrimidine derivatives
10/12/2005CN1679938A Pharmaceutical compositions
10/12/2005CN1679591A Steroidal sapogenins and their derivatives for treating alzheimer's disease
10/12/2005CN1679568A Use of n-substituted-1, 5-di deoxy-1, 5-imino-d-glucitol compounds for treating hepatitis virus infections
10/12/2005CN1679564A Method of treating of demyelinating diseases or conditions
10/12/2005CN1679559A Cancer treatment
10/12/2005CN1222292C Fulvestrant formulation
10/11/2005US6953810 Nicotinamide biaryl derivatives useful as inhibitors of PDE4 isozymes
10/06/2005WO2005092069A2 Chimeric infectious dna clones, chimeric porcine circoviruses and uses thereof
10/06/2005WO2005092039A2 Crosslinked amine polymers
10/06/2005WO2005055928A3 Zn2+ -chelating motif-tethered short -chain fatty acids as a novel class of histone deacetylase inhibitors
10/06/2005WO2005051330A3 METHOD FOR TREATING HUMAN TUMOR CELLS WITH A NEWCASTLE DISEASE VIRUS STRAIN HAVING A p53 INDEPENDENT ONCOLYTIC EFFECT
10/06/2005WO2005051312B1 Extracorporeal pathogen reduction system
10/06/2005WO2005048955A3 Preloading with macular pigment to improve photodynamic treament of retinal vascular disorders
10/06/2005WO2005048938A3 Anti-pecam therapy for metastasis suppression
10/06/2005WO2005046599A3 Alpha, beta-unsaturated sulfoxides for treating proliferative disorders
10/06/2005WO2005041879A3 COMBINATIONS COMPRISING AN Hsp90 INHIBITOR AND A PHOPHODIESTERASE INHIBITOR FOR TREATING OR PREVENTING NEOPLASIA
10/06/2005WO2005039499A3 Rapidly disintegrating film
10/06/2005WO2005037201A3 Treating bone-related disorders with selective androgen receptor modulators
10/06/2005WO2005037200B1 Composition comprising xanthoceras sorbifolia extracts, compounds isolated from same, methods for preparing same and uses thereof
10/06/2005WO2005034876A3 Use of cell lines to produce active therapeutic proteins
10/06/2005WO2005027844A3 Dna vaccine compositions and methods of use
10/06/2005WO2005027822A3 Stabilized formulations of phosphatidylserine
10/06/2005WO2005025519A3 Radiolabeled thymidine solid-phase extraction purification method
10/06/2005WO2005025518A3 Inhibition of inward sodium currents in cancer
10/06/2005WO2005020921A3 C-kit modulators and methods of use
10/06/2005WO2005018570A3 Optimization of impedance signals for closed loop programming of cardiac resynchronization therapy devices
10/06/2005WO2005016254A3 Methods and reagents for treating inflammation and fibrosis
10/06/2005WO2005009344A3 Acylated amino acid amidyl pyrazoles and related compounds
10/06/2005WO2005007110A3 Compositions and methods for hydrophobic drug delivery
10/06/2005WO2004093787A3 Use of glycodendrimer reagents for inhibiting adhesion by microorganisms
10/06/2005WO2004091527B1 Delivery systems of homogeneous thermoreversible low viscosity polymannan gum films
10/06/2005WO2004084812A3 Tamandarin analogs and fragments thereof and methods of making and using
10/06/2005WO2004084800A3 A3 receptor-mediated cardioprotective proteins and therapeutic and diagnostic methods of use
10/06/2005WO2004080406A3 Therapeutic compositions
10/06/2005WO2004069207A3 Immunogenic cd91 ligand-antigenic molecule complexes and fusion proteins
10/06/2005WO2004062566A3 Polyherbal preparation for the prevention of atherosclerosis and hyperlipidemia
10/06/2005WO2004041193A3 HUMAN TYPE II DIABETES GENE-Kv CHANNEL-INTERACTING PROTEIN (KChIP1) LOCATED ON CHROMOSOME 5
10/06/2005WO2004032877A3 Compositions, organisms and methodologies employing a novel human kinase
10/06/2005US20050222261 2-[2-(4-{2-[ethyl(2-fluorobenzyl)amino]-2-oxoethoxy}phenyl)ethoxy]benzoic acid; peroxisome proliferator-activated receptors alfa agonist; antidiabetic, hypotensive agent; obesity, elevated VLDL (Very Low Density Lipoproteins) and reduced HDL (High Density Lipoprotein) concentrations
10/06/2005US20050222177 Diseases with abnormal activation of the Abl, BCR-Abl, Bmx, CSK, TrkB, FGFR3, Fes, Lck, B-RAF, C-RAF, MKK6, alpha and beta SAPK2 kinases; antiproliferative; pyrrolo[2,3-d]pyrimidine-7-carboxylic acid [3-phenylcarbamoyl-phenyl]-amides and pyrrolo[3,2-c]pyridine analogs
10/06/2005US20050222153 Tyrosine kinase enzyme inhibitors as growth factor receptors and useful as antiproliferation agents
10/06/2005US20050222068 Method and antisense composition for selective inhibition of HIV infection in hematopoietic cells
10/06/2005US20050222013 Methods for the use of inhibitors of histone deacetylase as synergistic agents in cancer therapy
10/06/2005US20050220905 Tribulus terrestris, Turnera diffusa and Cinnamon cassia extracts in a precise weight ratio with Ginkgo biloba extract and a carrier or excipient; impotence, erectile dysfunction; reduced libido; frigidity; anorgasmia; side effect reduction; vasodilation; dopaminergic agents; phosphodiesterase inhibitor
10/06/2005US20050220871 Taste masking granules
10/06/2005US20050220802 Vaccine and method for treatment of motor neurone diseases
10/06/2005US20050220791 Novel of cytokine inhibitors
10/06/2005US20050220768 Materials and methods for treating ocular-related disorders
10/06/2005US20050220746 Epilatory Compositions
10/05/2005EP1581759A2 Methods for treating taxol-induced sensory neuropathy
10/05/2005EP1581527A2 Thrombopoietin mimetics
10/05/2005EP1581514A2 Chemical compounds
10/05/2005EP1581503A2 Ophthalmic compositions for treating ocular hypertension
10/05/2005EP1581500A2 Antibiotics containing borinic acid complexes and methods of use
10/05/2005EP1581497A2 Mitotic kinesin inhibitors
10/05/2005EP1581307A2 Irs modulators
10/05/2005EP1581251A2 Human growth hormone crystals and methods for preparing them
10/05/2005EP1581250A2 Oral formulations for proteins and polypeptides
10/05/2005EP1581246A2 Compositions for the treatment and prevention of nephropathy
10/05/2005EP1581243A2 Oral lactoferrin in the treatment of sepsis
10/05/2005EP1581232A1 3-(3,5-dioxo-4,5-dihydro-3h-(1,2,4)triazin-2-yl)-benzamide derivatives as p2x7-inhibitors for the treatment of inflammatory diseases
10/05/2005EP1581230A2 Method and compositions for treating anxiety
10/05/2005EP1581221A2 Substituted tricyclic gamma-carbolines as serotonin receptor agonists and antagonists
10/05/2005EP1581173A2 Encapsulated material released to generate perceivable sensorial indicia of discrete event occurence
10/05/2005EP1581156A2 Gilsonite derived pharmaceutical delivery compositions and methods
10/05/2005EP1581123A2 Antimicrobial suture coating
10/05/2005EP1581056A2 Therapeutic retroviral vectors for gene therapy
10/05/2005EP1581054A2 Treatment of hsv-related patholgies using ssdna
10/05/2005EP1158978B1 Medicament against dysmenorrhoea and premenstrual syndrome comprising lidocaine
10/05/2005CN1678579A Indole-3-sulphur derivatives
10/05/2005CN1678577A HMG-COA reductase inhibitors
10/05/2005CN1678303A Keto cannabinoids with therapeutic indications
10/05/2005CN1678261A Vaginal health products
10/05/2005CN1221286C Irradiation of ispaghula and product thereof
10/04/2005US6951650 Antigenic class of avian reoviruses
09/2005
09/29/2005WO2005046616A3 Viral propagation system and uses thereof
09/29/2005WO2005044179A3 Formulations containing astragalus extracts and uses thereof
09/29/2005WO2005039483A3 Anti-inflammatory pharmaceutical compositions for reducing inflammation and the treatment or prevention of gastric toxicity
09/29/2005WO2005025509A3 Methods and materials for treating autoimmune diseases and conditions
09/29/2005WO2005023205A3 Compositions and methods for yersinia pestis treatment
09/29/2005WO2005023192A3 Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione
1 ... 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 ... 295